Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky sells 1,195 shares for $32,265
ADPT•Insider share sale reported
- Adaptive Biotechnologies Chief Commercial Officer, MRD Susan Bobulsky sold 1,195 common shares on Sep. 15, 2026 at USD 27.
- Direct holdings were reported at 395,794 shares following the transaction.
